Gold, you were the one who opened my eyes to Wittenberg. I have always said Dr Moro is a hero to me and has done nothing wrong, but he fails to put friendship aside and spend shareholder money on the proper and logical expenses that would benefit all of us. We need an experienced biotech CEO, CFO, and a media relations dept. to put out regularly scheduled updates.
There were millions of shares squandered and money spent on embarassing penny newsletters that showed desperation, because they are unwilling to get the right experienced managers. Failure will lead to more failure and success will lead to further success.
There is no magic to this formula. I would consider how they disregard shareholders borders on malice. How can anyone justify the share price when there is no attempt by management to communicate PROPERLY to shareholders directly. Their website is outdated with projections from 2002. I feel we could have taken the high road we are ready to contact IBD, Wall Street Journal, Forbes or any number of legitimate publications on our progress in capitalizing on the only universal cancer marker. The investment world has a right and needs to know. Every day I hear about new discoveries and hopeful therapies. Why has no one heard of BioCurex? I'm not changing my mind on the technology, but I feel helpless by Dr Moro's failure to act now to do something about it.
